Page results
-
Information about the use of deferasirox iron chelation treatment for iron overload.
-
UCLH is one of the largest blood cancers treatment centres in Europe, with both inpatient beds and a comprehensive day care service. The service is the main treatment centre for patients from north and east London, and west Essex.
-
Breathlessness (dyspnoea) is an unpleasant sensation of uncomfortable, rapid or difficult breathing.
-
UCLH is the London Cancer Centre for the surgical treatment of prostate cancer.
-
An ambitious project has helped make the University College Hospital Outpatients Department much more pleasant and easy to navigate.
-
Meet Mohammod, a booking coordinator in our Proton Beam Therapy unit, who supports patients and their families throughout their treatment.
-
We are expanding the type of results that will be shared with patients through our patient portal MyCare UCLH.
-
Information about medications, vaccinations and travel for people with sickle cell disorder.
-
Mr Patrick Grover is a neurosurgeon with a particular expertise in the management of tumours of the skull base such as vestibular schwannomas and meningiomas, as well as Cerebral Aneurysms, AVMs and cavernomas.
-
Mr Pat O'Brien has been a consultant at UCLH since 1999 and specialises in caring for women with medical problems in pregnancy and complicated births. His research interests are in the same areas.
File results
-
FOI/2022/0392 - Replacement of patient trolleys
-
FOI/2022/0393 - COVID-19 patient treatment between 16/03/2020 - 16/06/2020
-
FOI/2022/0399 - Staff networks at the Trust
-
FOI/2022/0402 - Breast Cancer patients (any stage) treatments
-
FOI/2022/0405 - Treatments C1-esterase inhibitor & immunoglobulin treatments
-
FOI/2022/0408 - Date UCLH became smoke-free
-
FOI/2022/0412 - Mental health inpatient facilities
-
FOI/2022/0413 - Head and neck cancer and urothelial cancer patients treatment and clinical trials
-
FOI/2022/0421 - Paediatric autoimmune neuropsychiatric disorders
-
FOI/2022/0427 - Oesophageal and gastric cancer treatment